Collectively, our cellular, biochemical, and structural evidence supports a direct role for TPP1 in α-synuclein processing and suggests its potential to modulate α-synuclein in PD pathogenicity, as predicted by our knowledge graph–based AI model, highlighting the reliability of this model for therapeutic target identification. Here, TPP1 is linked to Parkinson disease.